With the introduction of contrast agents, advances in surface coil technology, and
development of new imaging protocols, contrast agent–enhanced magnetic resonance (MR) …

Dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI) is performed after the
administration of intravenous contrast medium to noninvasively access tumor vascular …

PURPOSE: To assess the relevance of the signal intensity time course for the differential
diagnosis of enhancing lesions in dynamic magnetic resonance (MR) imaging of the breast …

Purpose: To determine, in a meta-analysis, the diagnostic performance of contrast material–
enhanced magnetic resonance (MR) imaging in patients with breast lesions. Materials and …

PURPOSE: To define the range of normal contrast medium enhancement, the variability in
contrast medium enhancement patterns in healthy premenopausal breast parenchyma, and …

PURPOSE: To compare qualitative and quantitative magnetic resonance (MR)
mammographic features of breast lesions with histopathologic findings, especially tumor …

Dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI) is the acquisition of
serial MRI images before, during, and after the administration of an MR contrast agent …

The physiological parameters measured in the tracer kinetics modeling of data from a
dynamic contrast-enhanced magnetic resonance (MR) breast exam (blood flow-extraction …

The purpose of this study was to compare the ability of magnetic resonance imaging (MRI)
and mammography to determine the presence and extent of ductal carcinoma in situ (DCIS) …

Magnetic resonance imaging (MRI), after the administration of an extracellular, gadolinium-
based contrast medium, can be used to detect and characterize human tumours. The …